Ci62
Ci62 is a broad-spectrum antiviral compound under research for potential therapeutic applications. It belongs to a class of molecules designed to inhibit viral replication processes, particularly targeting RNA viruses. The compound is characterized by its chemical structure that allows it to interfere with viral replication enzymes or essential viral proteins, preventing the proliferation of viruses within host cells.
Research on Ci62 has indicated promising antiviral activity against a range of viruses, including coronaviruses, influenza,
The development of Ci62 is part of ongoing efforts to identify broad-spectrum antivirals capable of addressing
Research continues to explore optimal delivery methods, dosage, and potential side effects. The potential for resistance